SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$FUUU is a Solana-based memecoin that was launched on http://Pump.fun in March 2024. The project is themed around the Rage Guy character, a figure that originated in the rage comic era of the late 2000s and became widely recognized across internet culture. Following the launch, the original developer discontinued involvement with the token. At that point, the CTO team assumed responsibility for coordinating ongoing community efforts around the project.  The stated purpose of $FUUU is cultural rather than financial. It is designed as a “culture coin” that highlights Rage Guy as a symbolic and relatable figure. The character’s expression of frustration, commonly represented by the text “FFFFUUUU,” reflects emotions that are often tied to both cryptocurrency markets and everyday experiences. By building a token around this meme, the project aims to preserve a recognizable piece of internet history within a blockchain context.  Unlike projects that emphasize detailed roadmaps, technical milestones, or defined utility, $FUUU positions itself as a lighthearted and entertainment-driven token. There are no team allocations, no taxes, and no embedded promises of profit or financial return. The coin is intended solely for cultural engagement, community participation, and meme creation. Holders and community members are encouraged to contribute through content, discussion, and the continued use of Rage Guy imagery, but there are no obligations or formal expectations tied to the token.  The CTO team provides organizational support, and back end support such as hiring an artist and creatin websites, the community drives activity associated with the project. This includes creating and sharing memes, maintaining discussion channels, and ensuring the Rage Guy character remains present in contemporary internet culture. The project does not claim utility beyond its role as a culture coin, and its sustainability depends entirely on voluntary participation and ongoing community interest.  From a transparency standpoint, the on-chain parameters of the token are publicly visible. These include the mint authority status, freeze authority, liquidity details (whether burned or locked), and circulating supply information. Any locked or burn addresses are disclosed for the purpose of supporting accurate supply tracking on external platforms.  Rage Guy ($FUUU) should not be viewed as an investment. The token has no intrinsic value and provides no rights, revenue, or guarantees to holders. As with all cryptoassets, trading is highly risky, and participants are advised to conduct their own research and fully understand the risks involved. The project’s focus remains cultural preservation and community expression rather than financial

FUUUUUUUUUUUUUU

Investors are fueling intense volatility in FUUU as the community leans into its role as a high-risk, speculative meme asset that embodies a collective protest against current market conditions. While some participants dismiss the project as a potential rug pull or scam, others are actively accumulating positions in hopes of capturing explosive upward price momentum.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending following a binding agreement to deploy high-performance GPU infrastructure for Yotta Data Services in India, a deal projected to generate significant multi-year revenue. While bullish investors view the contract as institutional validation and a catalyst for long-term growth, the community remains actively divided as skeptics point to historical price declines, ongoing concerns over share dilution, and the need for greater transparency regarding operational execution.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is experiencing intense market volatility and high trading volume following an earnings report that exceeded top-line expectations, fueling significant retail momentum and aggressive short-squeeze activity. While bullish investors point to strategic acquisitions and defense-sector contracts as evidence of long-term commercial scalability, the community remains deeply divided, with many actively debating the stock's valuation, heavy short interest, and the sustainability of its growth-by-acquisition strategy.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

United Airlines is experiencing heightened volatility and market interest as investors weigh record holiday travel demand projections against ongoing operational headwinds, including government funding standoffs and regional weather-related flight disruptions. The community is actively debating the stock's valuation gap compared to its industry peers, with polarized discussions focused on whether the firm can successfully navigate capacity adjustments and fuel cost fluctuations to maintain its premium market position.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending as investors weigh its unique body-composition-focused obesity candidate, WVE-007, against the broader incretin market, with the community actively debating the durability and clinical efficacy of its muscle-sparing RNA interference platform following recent trial updates.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X Shares

Biotech investors are actively debating the sustainability of the sector's current rally, balancing bullish sentiment from rate cut expectations against concerns regarding technical overextension and potential headwinds from policy shifts. While some traders are aggressively scaling into leveraged positions like LABU to ride the sector's momentum, others are voicing caution, citing indicators of peak euphoria and historical resistance levels in XBI.

FS KKR Capital Corp. is an externally managed, non-diversified, and closed-end management investment company that has been elected to be regulated as a business development company. Its portfolio includes FS Investments and KKR Credit. The company was founded by Michael Craig Forman on December 21, 2007 and is headquartered in Philadelphia, PA.

FS KKR Capital Corp

FS KKR Capital is facing significant selling pressure as investors grapple with a substantial distribution cut and concerns over the company's software-heavy portfolio exposure, leading to discussions about potential further downside to NAV. While some bargain hunters are attempting to build positions at multi-year lows, the prevailing sentiment remains bearish with traders actively buying put options to hedge against the ongoing credit cycle uncertainty.

General Mills, Inc. engages in the manufacture and marketing of branded consumer foods sold through retail stores. Its product categories include snacks, ready-to-eat cereal, convenient meals, pet food, refrigerated and frozen dough, baking mixes and ingredients, yogurt, and ice cream. It operates through the following segments: North America Retail, International, North America Pet, and North America Foodservice. The North America Retail segment includes grocery stores, mass merchandisers, membership stores, natural food chains, drug, dollar and discount chains, convenience stores, and e-commerce grocery providers. The International segment refers to the retail and foodservice businesses outside of the US and Canada. The North America Pet segment includes pet food products sold in national pet superstore chains, e-commerce retailers, grocery stores, regional pet store chains, mass merchandisers, and veterinary clinics and hospitals. The North America Foodservice segment offers ready-to-eat cereals, snacks, refrigerated yogurt, frozen meals, unbaked and fully baked frozen dough products, baking mixes, and bakery flour. The company was founded by Cadwallader C. Washburn on June 20, 1928 and is headquartered in Minneapolis, MN.

General Mills, Inc.

General Mills is currently trending as investors debate its valuation near multi-year lows, weighing a strong dividend yield against ongoing pressure from changing consumer habits, increased reliance on private-label brands, and the broader impact of weight-loss drugs on snacking behavior. While many in the community view the stock as a contrarian defensive play priced for a worst-case scenario, sentiment remains divided between those expecting a rebound due to institutional value-buying and those concerned that the packaged food sector faces structural headwinds.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is currently experiencing significant downward price pressure and low trading volume, as investors wait for tangible evidence of Yartemlea's sales ramp following its FDA approval. The community is actively debating the impact of institutional shorting and option pinning while expressing strong conviction in the stock's long-term valuation based on the Novo Nordisk partnership and upcoming European regulatory milestones.

Blacksky Technology, Inc. is a space-based intelligence company, which engages in the business of delivering real-time imagery, analytics, and high-frequency monitoring of most critical and strategic locations, economic assets, and events. The firm is also involved in providing geospatial intelligence, imagery and related data analytic products and services, and mission systems that include the development, integration, and operation of satellite and ground systems to government and commercial customers. The company was founded in 2014 and is headquartered in Herndon, VA.

BlackSky Technology Inc - Ordinary Shares - Class A

BlackSky Technology is facing significant volatility ahead of its earnings release, with investors closely watching for updates on the Gen-3 satellite deployment schedule and the realization of a recent $30 million international defense contract. The community remains divided, as some traders focus on technical support levels and the company's long-term backlog growth, while others express frustration over past launch delays and erratic price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mangoceuticals Stock Doubles After Texas Lawsuit

Mangoceuticals stock jumps despite no fresh news, as lawsuit dispute, TRT sales surge, and platform shift shape investor sentiment.read more...

Regulatory Wins, Capital Flows, and Global Expansion Drive Market Momentum

A wave of regulatory clarity, strategic financing, and global expansion is reshaping pockets of the market, with companies across biotech, mobility, and emerging healthcare infrastructure positioning for outsized growth. $MGRX, $TOVX, $ZYBT, $FFAI, $TGNT

Penny Stocks To Follow Now - February 21st

Rackspace Technology, Cardio Diagnostics, Mana Capital Acquisition, Mangoceuticals, and BigBear.ai are the five Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny...

Penny Stocks To Watch Today - February 20th

Rackspace Technology, Cardio Diagnostics, and Mangoceuticals are the three Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are very low-priced shares...

Mangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally?

Shares of Mangoceuticals are trading sharply higher Friday afternoon after the company reported momentum for its $99-per-month TRT program.read more...

<ul class="summary-bullets"><li>Mangoceuticals believes the current crypto market offers a strategic opportunity to capitalize on current price levels.</li><li>The company has appointed Cube Group as the asset manager for its DAT.</li><li>As part of the MULTI-DAT framework, the company is pursuing a range of strategic digital asset and DeFi initiatives to enhance its treasury operations further.</li></ul>Health and wellness company Mangoceuticals <a href="https://stocktwits.com/symbol/MGRX">(MGRX</a>) on Friday announced that it is launching a Solana-focused digital asset treasury (DAT) of up to $100 million through its newly formed subsidiary, Mango DAT, in partnership with Cube Group.Cube Group has been appointed as the asset manager responsible for custody and execution.<h2 class="st-heading-2">Strategic Opportunity</h2>Mangoceuticals believes that the current crypto market offers a strategic opportunity to capitalize on current prices, enabling optimized entry points for long-term value creation. "We are optimistic about Solana’s future and confident this strategy will provide compelling, non-dilutive returns while positioning Mangoceuticals as a leader at the intersection of traditional finance and blockchain technology," said Jacob Cohen, Founder and CEO of Mangoceuticals.Solana’s&nbsp;<a href="https://stocktwits.com/coins/solana">price</a> was trading 1.7% higher at around $125.47 at the time of writing. Meanwhile, Mangoceuticals shares slumped nearly 47% on Friday. Retail sentiment around Mangoceuticals on Stocktwits trended in “extremely bullish” amid “extremely high” message volume.&nbsp;<figure class="image"><img style="aspect-ratio:633/73;" src="https://news.stocktwits-cdn.com/MGRX_PNG_9360d011fb.webp" alt="Retail sentiment around Mangoceuticals on Stocktwits trended in “extremely bullish” amid “extremely high” message volume. " width="633" height="73"></figure><h2 class="st-heading-2">MULTI-DAT Framework</h2>Mangoceuticals has recently filed a trademark&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://tsdr.uspto.gov/#caseNumber=99483190&amp;caseSearchType=US_APPLICATION&amp;caseType=DEFAULT&amp;searchType=statusSearch">application</a> for MULTI-DAT to the United States Patent and Trademark Office, signaling its strategic expansion into the digital asset sector.As part of the MULTI-DAT framework, the company is pursuing a range of strategic digital asset and DeFi initiatives to enhance its treasury operations further. This will allow the firm to conduct various financial operations, including facilitating virtual currency transactions and exchanges, processing electronic fund transfers, managing investment portfolios, and running blockchain-driven cryptocurrency services.&nbsp;By diversifying its activities, Mangoceuticals aims to mitigate the risks associated with market volatility, which often affects strategies that depend solely on token price movements.A Digital Asset Treasury is a type of firm that buys and holds cryptocurrencies on its balance sheet. One of the biggest DAT companies is Michael Saylor-backed Strategy (MSTR), which began buying bitcoin in 2020 and has been continuing to do so ever since. Notably, the number of DAT companies has expanded over the years.According to&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.dlapiper.com/en/insights/publications/2025/10/key-capital-market-trends-digital-asset-treasuries">DLA Piper</a>, as of September 2025, more than 200 companies had adopted DAT strategies, with more than 190 focused on BTC treasuries and another 10-20 on alternative digital assets.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Solana logo displayed on a phone screen and representation of cryptocurrencies are seen in this illustration photo taken in Krakow, Poland on August 21, 2021. (Photo Illustration by Jakub Porzycki/NurPhoto via Getty Images)

Mangoceuticals Announces Solana-Focused $100M Digital Asset Treasury, Sees ‘Compelling, Non-Dilutive Returns’

Mangoceuticals had also recently filed a trademark application for “MULTI-DAT” with the United States Patent and Trademark Office in a bid to expand into the digital asset space

Cryptocurrency

Mangoceuticals had also recently filed a trademark application for “MULTI-DAT” with the United States Patent and Trademark Office in a bid to expand into the digital asset space. 

Insider Selling: Mangoceuticals (NASDAQ:MGRX) CFO Sells 10,000 Shares of Stock

Mangoceuticals, Inc. (NASDAQ:MGRX - Get Free Report) CFO Eugene Johnston sold 10,000 shares of Mangoceuticals stock in a transaction that occurred on Friday, December 5th. The shares were sold at an...

Insider Selling: Mangoceuticals (NASDAQ:MGRX) Director Sells 125,000 Shares of Stock

Mangoceuticals, Inc. (NASDAQ:MGRX - Get Free Report) Director Alex Hamilton sold 125,000 shares of the stock in a transaction on Wednesday, November 19th. The shares were sold at an average price of...

<ul class="summary-bullets"><li>The obesity medications will be made available to both MangoRx and PeachesRx customers through Eli Lilly’s LillyDirect Self-Pay Pharmacy Solutions and Novo Nordisk’s NovoCare Pharmacy, Mangoceuticals said.</li><li>The drugs will be available for home delivery for as low as $499 per month, the company added.</li><li>A Novo Nordisk spokesperson noted in an emailed statement that the company “was not made aware of the announcement.”</li></ul>Shares of Mangoceuticals, Inc. (MGRX) jumped 23% in the pre-market session on Thursday after the telehealth company announced the launch of programs that provide direct access to authentic weight loss medicines from drugmakers Eli Lilly and Novo Nordisk.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://feeds.issuerdirect.com/news-release.html?newsid=5668113967057105&amp;symbol=MGRX">said</a> that it has launched two programs called MangoRx Direct and PeachesRx Direct to provide direct access to Lilly’s Zepbound and Novo’s Wegovy medicines.<h2 class="st-heading-2">How Will The Partnership Work?</h2>Customers can receive virtual consultations with providers on Mangoceuticals’ telehealth platform and get personalized obesity and weight management plans and also get their GLP-1 medicines delivered to them.The obesity medications will be made available to both MangoRx and PeachesRx customers through Eli Lilly’s LillyDirect Self-Pay Pharmacy Solutions and Novo Nordisk’s NovoCare Pharmacy. Both NovoCare and LillyDirect are aimed at providing medicines direct-to-consumer. While LillyDirect was launched last year, NovoCare was started earlier this year.The drugs will be available for home delivery for as low as $499 per month, the company said. Customers can also opt to pick up their prescriptions at a neighborhood pharmacy of their choice.“No insurance is required, making the programs ideal for self-pay, uninsured, underinsured and high-deductible patients,” Mangoceuticals CEO Jacob Cohen said.<h2 class="st-heading-2">Novo Nordisk’s Statement</h2>A Novo Nordisk spokesperson noted in an emailed statement that the company “was not made aware of the announcement issued this morning by Mangoceuticals. We do not have any agreement or partnership with this company.”<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/MGRX">MGRX stock</a> stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.MGRX stock is down by 27% this year and by 28% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/mrsn-stock-soars-pre-market-after-day-one-acquisition-deal/cLP9RQdRE3Q">MRSN Stock Soars Over 200% Pre-Market After Day One Acquisition Deal</a>For updates and corrections, email newsroom[at]stocktwits[dot]comEditor's Note: The story has been updated with Novo Nordisk's emailed statement.

Rising stock market chart on a trading board background.

Why Did Mangoceuticals Shares Rise Today?

 The company has launched two programs, MangoRx Direct and PeachesRx Direct, to provide access to Lilly’s Zepbound and Novo’s Wegovy medicines.

Equity

 The company has launched two programs, MangoRx Direct and PeachesRx Direct, to provide access to Lilly’s Zepbound and Novo’s Wegovy medicines.


Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company was founded on October 7, 2021 and is headquartered in Dallas, TX.

Mangoceuticals Inc

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

Current Price	$0.4873
Prev Close	$0.37
Open	$0.34
Dividend Yield	0.00%
50-Day Moving Average	$0.4212
Beta	0.95
Avg. Volume	20.1M
PE Ratio	-0.17

52-Week High	$2.88
52-Week Low	$0.162
Market Capitalization	$7.94M
EPS (Annual)	-$4.40
Price to Book	0.43
Revenue Per Employee	$205,291.00

MGRX
Mangoceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MGRX News

MGRXMangoceuticals Inc